These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10811289)

  • 1. Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and wistar fatty rats.
    Kimura M; Daimon M; Tominaga M; Manaka H; Sasaki H; Kato T
    Endocr J; 2000 Feb; 47(1):21-8. PubMed ID: 10811289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats.
    Tominaga M; Igarashi M; Daimon M; Eguchi H; Matsumoto M; Sekikawa A; Yamatani K; Sasaki H
    Endocr J; 1993 Jun; 40(3):343-9. PubMed ID: 7920888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
    Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
    Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats.
    Sugimoto M; Takeda N; Nakashima K; Okumura S; Takami K; Yoshino K; Hattori J; Ishimori M; Takami R; Sasaki A; Yasuda K
    Metabolism; 1998 Jul; 47(7):783-7. PubMed ID: 9667221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
    Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K
    Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
    Hevener AL; Reichart D; Janez A; Olefsky J
    Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
    O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA
    Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
    Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
    Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
    Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
    Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.
    Anil Kumar KL; Marita AR
    Br J Pharmacol; 2000 May; 130(2):351-8. PubMed ID: 10807673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.
    Oshida Y; Kako M; Nakai N; Shimomura Y; Li L; Sato J; Ohsawa I; Sato Y
    Endocr J; 1999 Oct; 46(5):723-30. PubMed ID: 10670760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatments for GH-induced insulin resistance.
    Sugimoto M; Takeda N; Hattori J; Yoshino K; Nakashima K; Okumura S; Ishimori M; Yasuda K
    Endocr J; 1999 Mar; 46 Suppl():S51-3. PubMed ID: 12054120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
    Sugiyama Y; Shimura Y; Ikeda H
    Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone reduces free fatty acid-induced insulin resistance in perfused rat hindquarter.
    Mokuda O; Sakamoto Y
    Diabetes Metab; 1998 Sep; 24(4):362-4. PubMed ID: 9805648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.
    Weinstein SP; Holand A; O'Boyle E; Haber RS
    Metabolism; 1993 Oct; 42(10):1365-9. PubMed ID: 8412752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of troglitazone on in vivo insulin action in normal rats.
    Lee MK; Olefsky JM
    Metabolism; 1995 Sep; 44(9):1166-9. PubMed ID: 7666790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.